Koninklijke Philips (PHG) Capital Expenditures (2009 - 2026)
Koninklijke Philips' (PHG) quarterly Capital Expenditures came in at -$85.5 million in Q1 2026, down 47.73% year-on-year from -$163.5 million in Q1 2025, and up 72.71% quarter-over-quarter from -$313.1 million in Q4 2025.
Koninklijke Philips (PHG) Capital Expenditures (2009 - 2026) Analysis & Trends
Koninklijke Philips' Capital Expenditures history runs 18 years deep, the most recent figure standing at -$85.5 million for Q1 2026.
- On a quarterly basis, Capital Expenditures fell 47.73% year-over-year to -$85.5 million in Q1 2026; TTM through Mar 2026 was -$749.6 million, a 1.93% decrease from a year earlier, with the FY2025 full-year figure at $313.1 million, down 7.56% from the prior year.
- Capital Expenditures climbed to -$85.5 million in Q1 2026 per PHG's latest filing, from -$313.1 million in the prior quarter.
- Across five years, Capital Expenditures topped out at -$57.9 million in Q1 2025 and bottomed at -$453.0 million in Q4 2022.
- The 5-year median for Capital Expenditures is -$142.6 million (2023), against an average of -$188.2 million.
- Across the five-year window, Capital Expenditures surged 43.68% in 2022 and tumbled 87.14% in 2023, its largest moves.
- Year by year, Capital Expenditures stood at -$453.0 million in 2022, then advanced by 18.06% to -$371.2 million in 2023, then increased by 8.74% to -$338.7 million in 2024, then rose by 7.56% to -$313.1 million in 2025, then surged by 72.71% to -$85.5 million in 2026.
- Per Business Quant, the three latest PHG Capital Expenditures figures stand at -$85.5 million (Q1 2026), -$313.1 million (Q4 2025), and -$217.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 90.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -85.46 Mn |
| Mar 31, 2026 | -85.46 Mn |
| Dec 31, 2025 | -313.13 Mn |
| Dec 31, 2025 | -313.13 Mn |
| Sep 30, 2025 | -217.44 Mn |
| Sep 30, 2025 | -217.44 Mn |
| Jun 30, 2025 | -133.57 Mn |
| Jun 30, 2025 | -133.57 Mn |
| Mar 31, 2025 | -57.85 Mn |
| Mar 31, 2025 | -57.85 Mn |
| Dec 31, 2024 | -338.74 Mn |
| Dec 31, 2024 | -338.74 Mn |
| Sep 30, 2024 | -256.98 Mn |
| Sep 30, 2024 | -256.98 Mn |
| Jun 30, 2024 | -81.84 Mn |
| Jun 30, 2024 | -81.84 Mn |
| Mar 31, 2024 | -89.08 Mn |
| Mar 31, 2024 | -89.08 Mn |
| Dec 31, 2023 | -371.20 Mn |
| Dec 31, 2023 | -371.20 Mn |